PMID: 8553305

Gan KH, Geus WP, Bakker W, Lamers CB, Heijerman HG
Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years.
Thorax. 1995 Dec;50(12):1301-4., [PubMed]
Sentences
No. Mutations Sentence Comment
41 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 8553305:41:101
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 8553305:41:52
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 8553305:41:59
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 8553305:41:138
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8553305:41:108
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 8553305:41:146
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 8553305:41:80
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 8553305:41:122
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 8553305:41:130
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 8553305:41:87
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 8553305:41:115
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 8553305:41:46
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Gly550*
X
ABCC7 p.Gly550* 8553305:41:94
status: NEW
view ABCC7 p.Gly550* details
DNA was analysed for the following mutations: E60X, R117H, A455E, AI507, AF508, G542X, S549N, G550X, G551D, R553X, R560T, R1162X, S1251N, W1282X, N1303K, 621 + 1G-+T, 1717-1G--+A. These mutations represent 80% ofthe expected cystic fibrosis mutations in The Netherlands. Login to comment
65 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 8553305:65:388
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 8553305:65:228
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 8553305:65:261
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 8553305:65:197
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 8553305:65:402
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 8553305:65:246
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 8553305:65:374
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 8553305:65:395
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 8553305:65:277
status: NEW
view ABCC7 p.Glu60* details
ABCC7 p.Gly550*
X
ABCC7 p.Gly550* 8553305:65:381
status: NEW
view ABCC7 p.Gly550* details
Table 3 CFTR mutations in 278 chromosomes of adult cystic fibrosis patients Early diagnosis Late diagnosis (n= 118) (n=25) n % n % AF508s 175 74-2 18 36-0 A455Em 12 5-1 14 28-0 1717-15 6 2-5 1 2-0 G542X' 4 1-7 - W1282X1 3 1-3 - R553X' 1 04 1 2-0 S1251N 2 0-8 - N1303K' 1 0 4 - E60X 1 0-4 3 6-0 Not identified 31 13-2 13 26-0 Total 236 50 Mutations not found: RI 17H, AI507, S549N, G550X, G551D, R560T, R1162X, 621+1G-+T. Login to comment
69 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 8553305:69:4
status: NEW
view ABCC7 p.Ala455Glu details
The A455E mutation was relatively frequent in the LD group. Login to comment
98 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 8553305:98:136
status: NEW
view ABCC7 p.Ala455Glu details
Most of those diagnosed at 16 years or older were pancreatic sufficient, which is closely related to the type of CFTR mutation.2829 The A455E mutation was frequently found among this group of patients and preliminary studies indicate that this mutation, known to be related to pancreatic sufficiency,29 may be associated with mild pulmonary disease.30 It seems that other CFTR mutations (some ofwhich are still unidentified) in patients diagnosed late are associated with pancreatic sufficiency and also with mild pulmonary disease. Login to comment